Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Neurologist. 2012 Mar;18(2):99–101. doi: 10.1097/NRL.0b013e318248ea3c

Table 2.

In-hospital outcomes in patients over the age of 80 who were treated with intravenous recombinant tissue plasminogen activator compared to those who were not treated (reference).

Univariate (Odds ratio, 95%
confidence interval; or
parameter estimate for
linear regression)ǂ
Multi-variable analysis
(Odds ratio, 95%
confidence interval; or
parameter estimate for
linear regression)*ǂ
Death 2.7(0.9–8.1) 1.2(0.3–4.3)
Discharge other than to home 6.5(2.5–16) 2.9(0.9–8.9)
Length of stay difference (p-value) 3.7(0.04) 3.4(0.04)
*

adjusted for age, sex, race-ethnicity, and pre-treatment NIHSS

ǂ

Odds ratios represent odds of the outcomes among those treated versus those who were not treated.